- Home
- CVAC vs ATRO Comparison
CVAC vs ATRO Comparison
Compare CVAC & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- ATRO
- Stock Information
- Founded
- CVAC 2000
- ATRO 1968
- Country
- CVAC Germany
- ATRO United States
- Employees
- CVAC N/A
- ATRO N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- ATRO Military/Government/Technical
- Sector
- CVAC Health Care
- ATRO Industrials
- Exchange
- CVAC Nasdaq
- ATRO Nasdaq
- Market Cap
- CVAC 1.2B
- ATRO 1.2B
- IPO Year
- CVAC 2020
- ATRO N/A
- Fundamental
- Price
- CVAC $5.41
- ATRO $47.82
- Analyst Decision
- CVAC Hold
- ATRO Strong Buy
- Analyst Count
- CVAC 3
- ATRO 1
- Target Price
- CVAC $6.83
- ATRO $49.00
- AVG Volume (30 Days)
- CVAC 404.4K
- ATRO 1.0M
- Earning Date
- CVAC 11-11-2025
- ATRO 11-05-2025
- Dividend Yield
- CVAC N/A
- ATRO N/A
- EPS Growth
- CVAC N/A
- ATRO N/A
- EPS
- CVAC 1.01
- ATRO N/A
- Revenue
- CVAC $599,540,810.00
- ATRO $822,852,000.00
- Revenue This Year
- CVAC N/A
- ATRO $9.05
- Revenue Next Year
- CVAC $23.83
- ATRO $6.88
- P/E Ratio
- CVAC $5.40
- ATRO N/A
- Revenue Growth
- CVAC 675.15
- ATRO 10.99
- 52 Week Low
- CVAC $2.37
- ATRO $14.13
- 52 Week High
- CVAC $5.72
- ATRO $48.85
- Technical
- Relative Strength Index (RSI)
- CVAC 53.41
- ATRO 74.70
- Support Level
- CVAC $5.33
- ATRO $43.98
- Resistance Level
- CVAC $5.45
- ATRO $46.71
- Average True Range (ATR)
- CVAC 0.03
- ATRO 1.63
- MACD
- CVAC 0.01
- ATRO 0.35
- Stochastic Oscillator
- CVAC 66.10
- ATRO 85.42
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.